Drug Shortage Report for REVATIO

Last updated on 2017-03-18 History
Report ID 2036
Drug Identification Number 02279401
Brand name REVATIO
Common or Proper name REVATIO
Company Name PFIZER CANADA ULC
Active Ingredient(s) SILDENAFIL
Strength(s) 20MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 6x15
ATC code C02
ATC description OTHER ANTIHYPERTENSIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-01-19
Estimated end date 2017-03-15
Actual end date 2017-03-17
Shortage status Resolved
Updated date 2017-03-18
Company comments Resolved March 17, 2017 / Résolu 17 mars 2017
Health Canada comments
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-03-13 English Compare
v2 2017-03-13 French Compare
v3 2017-03-17 English Compare
v4 2017-03-17 French Compare
v5 2017-03-18 English Compare